SC:Clinical Trials of 162 New Chemicals continue to be on Hold

Oct 22, 2013 15:07 IST

Supreme Court of India on 21 October 2013 ruled that the clinical trials of 162 new chemical entities will continue to be on hold. The court added that 157 new chemical entities which were cleared for clinical trials on 31 December 2012, would be reviewed by the two apex committees. The technical and apex committees would look into the assessment of risk versus benefits to the patients, innovation through existing therapeutic options and the unmet medical needs of the country. The committees will ascertain whether the new chemical entities that are being put to clinical trials are actually required in the country.

The court gave the judgment after reviewing the clearance for clinical trials of 157 new chemical entities by the National Drugs Advisory Committee and the Drug Controller General of India.

The next hearing of the matter will take place on16 December 2013.

Quick Digest

Who: Supreme Court of India

When: 21 October 2013

Is this article important for exams ? Yes14 People Agreed
Read more Current Affairs on: Clinical trials , Supreme Court , new chemicals

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK